PMG Board of Directors

Jennifer Byrne

Jennifer Byrne

Chairman of the Board

View Bio
John Vann

John Vann

Director

View Bio
Joel Lanik

Joel Lanik

Director

View Bio

Jennifer ByrneJennifer Byrne


Chairman of the Board

Jennifer Byrne is Chief Executive Officer of PMG Research, Inc. (PMG) and serves on its Board of Directors. In this role, Jennifer is responsible for driving the company’s growth as a leader of one of the largest wholly owned and operated Integrated Site Networks in the U.S.  PMG Research delivers a standardized clinical research infrastructure to large physician practices and mid-market organized systems of care with a commitment to deliver improved care, decreased costs, and improved patient satisfaction through clinical trial participation as a care option.  Jennifer spends much of her time with health care providers learning more about the challenges they face in connecting the right patients to the right trials. This understanding leads to better solutions for both the health care system and the Pharma and CRO clients of PMG. 

Jennifer has concentrated her career in the clinical research site sector for over 25 years.  During her long-term tenure at PMG she and her team have completed over 7,200 Phase I-IV clinical trials which have included over 100,000 research volunteers.  Jennifer was recognized as a CenterWatch Top 25 Innovator and currently serves as an Advisory Board member to CISCRP and the Wake Forest Institute of Regenerative Medicine, and Board member of the Hospice Foundation and The Greater Gift Initiative. Jennifer earned her bachelor of science in Nutrition at Texas A&M University.

Charles HauserCharles Hauser


Director

Charles H. Hauser currently serves as CEO of Piedmont Stone Center, a physician-owned lithotripsy management company which began in 1983. As sole proprietor of a medical management services company since 1978, Mr. Hauser is also the member manager of Physician Discoveries, LLC serving over 3000 physicians in the United States. From 1980 until 2006, Mr. Hauser was the President and Co-founder of Piedmont Medical Research Associates, Inc., which is now PMG Research.

Mr. Hauser earned his Bachelor of Arts in Chemistry at the University of North Carolina at Chapel Hill and completed a Master of Business with a concentration in Finance and Accounting from the University of North Carolina at Greensboro. He has been involved in ongoing studies at Wake Forest and Duke Universities. In addition to corporate boards, Mr. Hauser serves or has served on the Boards of Piedmont Craftsmen Inc., Southeastern Center for Contemporary Art, Horne Creek Living Historical Farm, Data Max, Hospice and Palliative Care Center, Inc., Senior Services, Inc., and Centenary United Methodist Church. He served a nine year appointment to the State Health Coordinating Council and six years to the Winston-Salem Parks and Recreation Commission. He currently is appointed to the North Carolina Medical Care Commission.

Joel LanikJoel Lanik


Director

Mr. Lanik is a Partner at Frontier Capital and has more than 13 years of growth equity, operational and advisory experience. He is a current board member of WilsonHCG, JobApp, ConnectSolutions, eVerifile, Conclusive Analytics, Cash Cycle Solutions, PMG Research, and Business Intelligence Advisors. Prior to rejoining Frontier in 2007, Mr. Lanik was Vice President of Finance and Strategy at LURHQ, a leading provider of managed IT security services, where he was instrumental in LURHQ's profitable growth and successful sale to SecureWorks. Before this operating role, Mr. Lanik was part of the Fund I investment team with Frontier. Mr. Lanik graduated from Duke University and received his MBA from the Darden School of Business at the University of Virginia. He is also a Chartered Financial Analyst.

John VannJohn Vann


Director

John serves as a business consultant with The Summit Companies, a risk and strategic management consulting firm in Bristol and Knoxville, Tennessee.  Prior to joining Summit, John was with Chiltern International, Inc., a UK-based CRO, serving until 2012 as its EVP for Corporate Development, responsible globally for facilitating growth opportunities through strategic relationships and acquisitions. John’s career in clinical research began in 1990 when he co-founded Clinical Trial Management Services, Inc. (CTMS), serving as its CEO until its acquisition by Chiltern in 2007. John holds a BA in Economics from Wake Forest University, where he serves on the University's Board of Trustees and the Advisory Board of the Wake Forest Institute for Regenerative Medicine. Locally, John is involved on the boards of Citizens Bank, United Way of Bristol, Healing Hands Health Center, Bristol Regional Medical Center, and The Paramount Chamber Players. John also is an Elder of First Presbyterian Church in Bristol, where he is active on the Evangelism and Outreach committee.